Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable Progression

Purpose: The present retrospective study aimed to evaluate the efficacy and safety of camrelizumab addition to transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC) with TACE-related untreatable progression (UP). Methods: Patients with HCC who received addition of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yanqiao, Liu, Ziyi, Makamure, Joyman, Kan, Xuefeng, Song, Songlin, Liu, Yiming, Qian, Kun, Zheng, Chuansheng, Liang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Hepatobiliary Cancers: The Mechanisms and Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583233/
https://www.ncbi.nlm.nih.gov/pubmed/36259117
http://dx.doi.org/10.1177/15330338221131385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583233/
https://www.ncbi.nlm.nih.gov/pubmed/36259117
http://dx.doi.org/10.1177/15330338221131385

Ejemplares similares